Crossmark

Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: Long follow-up analysis from a single transplant center

Crossref DOI link: https://doi.org/10.1016/j.medcli.2024.09.023

Published Print: 2025-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ormazabal Vélez, Irati

Galbete Jiménez, Arkaitz

Sánchez-Escamilla, Miriam

Marcos-Jiménez, Ana

Fernández-Ruiz, Elena

Salmanton-García, Jon

Bermúdez Rodríguez, Arancha

Figuera Álvarez, Ángela
Funding

Funding for this research was provided by:

Universidad Autónoma de Madrid
License Information

Text and Data Mining valid from 2025-03-01

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2024-11-03
More Information

This article is maintained by: Elsevier

Article Title: Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: Long follow-up analysis from a single transplant center

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2024.09.023

Content Type: article

Copyright: © 2024 The Author(s). Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below